These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 24891607)

  • 21. Skeletal Muscle Involvement in Antisynthetase Syndrome.
    Noguchi E; Uruha A; Suzuki S; Hamanaka K; Ohnuki Y; Tsugawa J; Watanabe Y; Nakahara J; Shiina T; Suzuki N; Nishino I
    JAMA Neurol; 2017 Aug; 74(8):992-999. PubMed ID: 28586844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antisynthetase syndrome with anti-Jo1 antibodies in 48 patients: pulmonary involvement predicts disease-modifying antirheumatic drug use.
    Stanciu R; Guiguet M; Musset L; Touitou D; Beigelman C; Rigolet A; Costedoat-Chalumeau N; Allenbach Y; Hervier B; Dubourg O; Maisonobe T; Charuel JL; Behin A; Herson S; Amoura Z; Grenier P; Benveniste O
    J Rheumatol; 2012 Sep; 39(9):1835-9. PubMed ID: 22859355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pulmonary histopathologic manifestations of the anti-PL7/antithreonyl transfer RNA synthetase syndrome.
    Yousem SA; Schneider F; Bi D; Oddis CV; Gibson K; Aggarwal R
    Hum Pathol; 2014 Jun; 45(6):1199-204. PubMed ID: 24767252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 64-year-old woman with interstitial lung disease and positive antibodies against aminoacyl-transfer RNA synthetases in the absence of myositis: presentation of an anti-PL-12 positive antisynthetase syndrome.
    Ghysen K; Leys M
    Acta Clin Belg; 2018 Oct; 73(5):389-392. PubMed ID: 29173135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-EJ antibody positive interstitial lung disease with skin changes at the fingertips.
    Ota M; Kihara M; Takamura A; Kohsaka H
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(2):150-3. PubMed ID: 27212602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics and prognostic analysis of idiopathic inflammatory myopathy with positive anti-aminoacyl-tRNA synthetase antibodies: A single center experience.
    Zhang D; Wang H; Zhou X; Yang J; Liu Y; Wang W; Jiang P; Fan B
    Immun Inflamm Dis; 2023 Nov; 11(11):e1085. PubMed ID: 38018600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Myositis-specific autoantibodies].
    Fujimoto M
    Brain Nerve; 2013 Apr; 65(4):449-60. PubMed ID: 23568993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myositis-related interstitial lung disease and antisynthetase syndrome.
    Solomon J; Swigris JJ; Brown KK
    J Bras Pneumol; 2011; 37(1):100-9. PubMed ID: 21390438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anti-synthetase syndrome].
    Novak S
    Reumatizam; 2012; 59(2):53-7. PubMed ID: 23745457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antisynthetase myopathy].
    Suzuki S
    Rinsho Shinkeigaku; 2020 Mar; 60(3):175-180. PubMed ID: 32101845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics of interstitial lung diseases positive to different anti-synthetase antibodies.
    Jiang M; Dong X; Zheng Y
    Medicine (Baltimore); 2021 May; 100(19):e25816. PubMed ID: 34106621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ["Mechanic's hands" during antisynthetase syndrome: a marker of systemic involvement?].
    Nahas O; Haddad F; Maalouly G
    Ann Dermatol Venereol; 2015 Mar; 142(3):189-92. PubMed ID: 25620556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies.
    Yoshifuji H; Fujii T; Kobayashi S; Imura Y; Fujita Y; Kawabata D; Usui T; Tanaka M; Nagai S; Umehara H; Mimori T
    Autoimmunity; 2006 May; 39(3):233-41. PubMed ID: 16769657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature.
    Kalluri M; Sahn SA; Oddis CV; Gharib SL; Christopher-Stine L; Danoff SK; Casciola-Rosen L; Hong G; Dellaripa PF; Highland KB
    Chest; 2009 Jun; 135(6):1550-1556. PubMed ID: 19225060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel endotypes of antisynthetase syndrome identified independent of anti-aminoacyl transfer RNA synthetase antibody specificity that improve prognostic stratification.
    Wu S; Xiao X; Zhang Y; Zhang X; Wang G; Peng Q
    Ann Rheum Dis; 2024 May; 83(6):775-786. PubMed ID: 38395605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characterisation of a multicentre nationwide cohort of patients with antisynthetase syndrome.
    Martins P; Dourado E; Melo AT; Samões B; Sousa M; Freitas R; Lourenço MH; Fernandes B; Costa E; Parente H; Martins F; Fonseca JE; Cordeiro I; Romão VC; Khmelinskii N; Campanilho-Marques R
    ARP Rheumatol; 2022 Nov; 1(ARP Rheumatology, nº3 2022):190-196. PubMed ID: 35891592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two novel anti-aminoacyl tRNA synthetase antibodies: Autoantibodies against cysteinyl-tRNA synthetase and valyl-tRNA synthetase.
    Muro Y; Yamashita Y; Koizumi H; Ogawa-Momohara M; Takeichi T; Mitsuma T; Akiyama M
    Autoimmun Rev; 2022 Dec; 21(12):103204. PubMed ID: 36191779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical features and prognoses of anti-MDA5 and anti-aminoacyl-tRNA synthetase antibody double-positive dermatomyositis patients.
    Chen X; Zhang L; Jin Q; Lu X; Lei J; Peng Q; Wang G; Ge Y
    Front Immunol; 2022; 13():987841. PubMed ID: 36110863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antisynthetase syndromes].
    Bauhammer J; Fiehn C
    Z Rheumatol; 2019 Sep; 78(7):645-655. PubMed ID: 31346706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antisynthetase syndrome: a retrospective study of 14 patients].
    Dieval C; Ribeiro E; Mercié P; Blanco P; Duffau P; Longy-Boursier M
    Rev Med Interne; 2012 Feb; 33(2):76-9. PubMed ID: 22204922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.